TriSalus Life Sciences Inc. (NASDAQ: TLSI) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TRISALUS LIFE SCIENCES INC.

TriSalus Life Sciences Inc. (NASDAQ: TLSI)
Listen to this Section


$4.13
-0.0100 ( -0.24% ) N/A

TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.

Market Data


Open $4.13
Previous Close $4.14
Volume N/A
Market Cap $254.26M
Day Range $3.76 - $4.08
52 Week Range $2.20 - $7.95
Shares Outstanding 61.42M
Change % -0.24%
Net Change ▼ -0.0100
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryMedical Specialities
IPO Year2023
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -2,195,815.00

Date Type Amount Purchased Purchaser
2023-08-14 Sale -35000.00 Desai Arjun JJ

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Oct 01, 2025
8-k 8K-related 13 Aug 29, 2025
4 Insider transactions 1 Aug 29, 2025
4 Insider transactions 1 Aug 15, 2025
8-k 8K-related 15 Aug 12, 2025
10-q Quarterly Reports 89 Aug 12, 2025
8-k 8K-related 15 Jul 24, 2025
3 Insider transactions 1 Jul 10, 2025

Latest News